What 5 Analyst Ratings Have To Say About Astrana Health
Portfolio Pulse from Benzinga Insights
Astrana Health (NASDAQ:ASTH) has received positive analyst ratings, with 4 out of 5 analysts being bullish. Recent price targets have increased, with an average target of $61.2, up 19.53% from the previous $51.20. Analysts have raised their ratings and price targets, reflecting a positive outlook on the company's financial performance, including strong revenue growth and profitability.
October 03, 2024 | 1:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Astrana Health has received predominantly bullish ratings from analysts, with a significant increase in average price targets. This reflects a positive sentiment towards the company's financial performance and future prospects.
The article highlights that 4 out of 5 analysts are bullish on Astrana Health, with recent upgrades in ratings and price targets. The average price target has increased by 19.53%, indicating strong confidence in the company's future performance. This is supported by Astrana Health's impressive revenue growth and profitability metrics, which exceed industry standards. Such positive analyst sentiment and financial performance are likely to drive the stock price up in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100